PharmaResources Current Valuation vs. Number Of Employees
| 301230 Stock | 26.86 1.21 4.31% |
For PharmaResources profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PharmaResources to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PharmaResources Co Ltd utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PharmaResources's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PharmaResources Co Ltd over time as well as its relative position and ranking within its peers.
PharmaResources |
PharmaResources Number Of Employees vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining PharmaResources's current stock value. Our valuation model uses many indicators to compare PharmaResources value to that of its competitors to determine the firm's financial worth. PharmaResources Co Ltd is the top company in current valuation category among its peers. It also is number one stock in number of employees category among its peers . The ratio of Current Valuation to Number Of Employees for PharmaResources Co Ltd is about 3,576,056 . Comparative valuation analysis is a catch-all model that can be used if you cannot value PharmaResources by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for PharmaResources' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.PharmaResources Current Valuation vs. Competition
PharmaResources Co Ltd is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 10.83 Trillion. PharmaResources adds roughly 3.74 Billion in current valuation claiming only tiny portion of equities under Health Care industry.
PharmaResources Number Of Employees vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
PharmaResources |
| = | 3.74 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
PharmaResources |
| = | 1.05 K |
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
PharmaResources Number Of Employees vs Competition
PharmaResources Co Ltd is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 2.37 Million. PharmaResources adds roughly 1,047 in number of employees claiming only tiny portion of equities under Health Care industry.
PharmaResources Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in PharmaResources, profitability is also one of the essential criteria for including it into their portfolios because, without profit, PharmaResources will eventually generate negative long term returns. The profitability progress is the general direction of PharmaResources' change in net profit over the period of time. It can combine multiple indicators of PharmaResources, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PharmaResources is entity of China. It is traded as Stock on SHE exchange.
PharmaResources Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on PharmaResources. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of PharmaResources position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the PharmaResources' important profitability drivers and their relationship over time.
Use PharmaResources in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PharmaResources position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmaResources will appreciate offsetting losses from the drop in the long position's value.PharmaResources Pair Trading
PharmaResources Co Ltd Pair Trading Analysis
The ability to find closely correlated positions to PharmaResources could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PharmaResources when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PharmaResources - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PharmaResources Co Ltd to buy it.
The correlation of PharmaResources is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PharmaResources moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PharmaResources moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PharmaResources can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your PharmaResources position
In addition to having PharmaResources in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Mid Cap ETFs Thematic Idea Now
Mid Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Mid Cap ETFs theme has 70 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Mid Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in PharmaResources Stock
To fully project PharmaResources' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of PharmaResources at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include PharmaResources' income statement, its balance sheet, and the statement of cash flows.